mo:re
PrivateLast Round
Seed
Mar 26, 2025
Total Funding Raised
$2.67M
Momentum Score
25 /100
Company Overview
mo:re is a biotechnology company that has developed a lab platform, the MO:BOT, which automates 3D cell culture and downstream assays to standardize drug discovery and reduce reliance on animal testing.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Workflow Automation, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
mo:re Comps
Public and private peers based on sector, stage, and business model.
mo:re Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 26, 2025 |
mo:re Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NEDGEX | Seed |
| InnoVentureFonds | Seed |
mo:re Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about mo:re's valuation, stock price, and market status.
